Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,431
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.1%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 301–331 of 331 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05773079	Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell Carcinoma	not yet recruiting	Phase 2	28	Nanfang Hospital, Southern Medical UniversityOTHER	0	Apr 1, 2024	clinicaltrials
NCT06331845	Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma	not yet recruiting	Phase 2	39	Fujian Cancer HospitalOTHER_GOV	0	Mar 26, 2024	clinicaltrials